The research on 17,000 adults who were overweight or obese found that the risk of heart attack, stroke or cardiac death was cut by 20 per cent for those on semaglutide – the drug known as either ...
Weight loss injections like Ozempic might be a game-changer for heart health. A new study suggests these drugs can significantly reduce the risk of heart attacks and strokes in obese patients ...
Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has found. The anti-obesity injections could reduce the risk in obese people ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Patients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease after three years of treatment, according to an analysis of data from the five-year ...
An anti-obesity drug could have additional health benefits including reducing the risk of heart attacks and strokes a new study has revealed. A five-year study was carried out by a team led ...
FAT jabs could be the cancer hope of the future after early studies found they reduce the risk of tumours. The world’s top ...
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and Type 2 diabetes, a new study says.
A study links the popular sugar substitute, an alternative for people who are diabetic or trying to lose weight, to an elevated risk of cardiovascular events. Separately, a new drug combination is ...
A weight loss injection could reduce the risk of heart attacks and benefit the cardiovascular health of adults, according to a study on what could be the largest medical breakthrough since statins.
Weight loss jabs cut the risk of heart death by a fifth, a study has found, with medics calling for them to be prescribed like statins. The research – the largest ever trial of the injections ...